V. V. Khvostovoi

V. V. Khvostovoi

Auto-generated profile, based on publicly available information

V. V. Khvostovoi

Kursk State Medical University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2023 in Siberian journal of oncology
Verified
Journal Article
Open access
PDF file
ISIrina Stanoevich
Irina Stanoevich
VKV. V. Khvostovoy
V. V. Khvostovoy
ETE. I. Tishina
E. I. Tishina
VDV. I. Dyachkova
V. I. Dyachkova
DPDmitry V Petrochenko
Dmitry V Petrochenko
ISIrina Vasil’evna Stanoevich
Irina Vasil’evna Stanoevich
Purpose. To reflect the current understanding of the frequency, molecular mechanisms, and means of overcoming alopecia in cancer patients, taking into account the fundamental data of recent years on the physiology of the hair follicle and the pharmacological profile of the toxicity of anticancer drugs.Material and Methods. A literature search using Medline, Pubmed, etc. databases was carried out. More than 200 publications devoted to the study of alopecia were found, of which 42 were included in this review.Results. Chemotherapy-induced hair loss is a common adverse effect in cancer patients undergoing treatment. The frequency and molecular mechanism of the development of alopecia are related to the pharmacological features of the drug-based treatments, initial nutritional premorbid status, and predisposing polymorphisms of genes involved in drug conversion and excretion. Focal or diffuse alopecia may be the first sign of malignant growth within the paraneoplastic syndrome, primary or metastatic malignancies of the scalp, or be a manifestation of nutritional insufficiency. Baldness negatively affects the psycho-emotional state of patients, exacerbating depressive disorders, anxiety, reducing self-esteem and adherence to treatment. Thus, prevention or rapid overcoming of alopecia can significantly improve the quality of life of cancer patients. The use of scalp cooling or ‘cold caps’ is proven to be an effective way of combating chemotherapy-induced hair loss.Conclusion. Further studies are needed to prevent and treat alopecia in cancer patients.

1 January 2022 in Человек и его здоровье
Verified
Journal Article
Open access
PDF file
GPGladchenko Mikhail P.
Gladchenko Mikhail P.
ABArtyushkova Elena B.
Artyushkova Elena B.
FGFrolova Oxana G.
Frolova Oxana G.
MSMal Galina S.
Mal Galina S.
KVKhvostovoy Vladimir V.
Khvostovoy Vladimir V.
PRPuchak Irina R.
Puchak Irina R.
The objective of this work was to investigate in experiments on laboratory rats the possibility of reducing the cardiotoxicity of the anticancer drug Mitomycin C by mixing it with Mesogel before injection and using Mexicor® as a cardioprotective agent. Materials and methods. To carry out the study, 70 male Wistar rats were used. The body weight of laboratory animals at the beginning of the experimental study ranged from 180 to 220 grams. Intraperitoneal administration of Mitomycin C at a dose of 4 mg/kg once at the start of the study was used. When Mitomycin C was administered together with Mesogel, the drugs were combined under aseptic conditions before intraperitoneal administration, and Mesogel was administered at a volume of 10.7 ml/kg. The drug Mexicor® was administered in the form of intramuscular injections at a dose of 60 mg/kg per day for 14 days. Results. After intraperitoneal injection of the drug "Mitomycin C" at a dose of 4 mg / kg, a noticeable decrease in the contractility of the rat myocardium during exercise tests was observed only on the 14th day. The use of "Mitomycin C" mixed with "Mesogel" during intraperitoneal administration had a positive effect, but did not completely exclude the manifestation of the cardiotoxic effects of "Mitomycin C". The greatest efficiency was demonstrated in groups of animals that received "Mitomycin C" in a mixture with "Mesogel" together with the cytoprotective drug "Mexicor®". Conclusion. The combination of "Mitomycin C" immobilisation in "Mesogel" together with the cytoprotective drug "Mexicor®" was found to eliminate the cardiotoxic effects of "Mitomycin C" to the greatest extent.

15 November 2024 in Siberian journal of oncology
Verified
Journal Article
Open access
PDF file
ISIrina Stanoevich
Irina Stanoevich
VKV. V. Khvostovoy
V. V. Khvostovoy
DPDmitry V Petrochenko
Dmitry V Petrochenko
ASA. Yu. Salamatina
A. Yu. Salamatina
VIVitaliy Ioutsi
Vitaliy Ioutsi
IEI. V. Ermilov
I. V. Ermilov
The purpose of the study was to carry out a systematic analysis of the data available in the modern literature on the essentiality of selenium in biological systems and the importance of selenoproteins in oncogenesis.Material and Methods. The publications were analyzed using Scopus (415), PubMed (521), Web of Science (139), eLibrary.ru (240) databases. To obtain full-text documents, the electronic resources PubMed Central (PMC), Science Direct, Research Gate, eLibrary.ru were used.Results. The need to use selenium compounds for the prevention and treatment of malignant neoplasms is controversial, and some selenoproteins have demonstrated a permissive role in oncogenesis, thus requiring further in-depth study in neoplasms of various histogenesis.Conclusion. It is necessary to continue comprehensive molecular studies of bioorganic selenium compounds at the morphological, ultrastructural and biochemical levels in tumors of various localizations, depending on the genetic characteristics of the studied population and the geochemical characteristics of the region.

27 February 2025 in Siberian Scientific Medical Journal
Verified
Journal Article
Open access
PDF file
EBE. E. Babykhin
E. E. Babykhin
VKV. V. Khvostovoi
V. V. Khvostovoi
KKK. E. Kelyamova
K. E. Kelyamova
ETE. D. Tsnobiladze
E. D. Tsnobiladze
AKA. I. Klementyeva
A. I. Klementyeva
SSS. Yu. Shumakova
S. Yu. Shumakova
Merkel cell carcinoma is a rare tumour characterized by a high potential for metastasis and local recurrence. The nonspecific clinical picture of the disease often leads to late diagnosis, which creates certain difficulties in the further management of patients. The predominant number of patients with Merkel cell carcinoma are elderly and senile persons, whose comorbid status requires a personalized approach to treatment. This article presents a clinical observation of successful treatment of an 84-year-old woman with Merkel cell carcinoma of the infraorbital region. The patient came to the clinic with complaints of a skin tumor in the infraorbital region on the right, which was verified at her place of residence as Merkel carcinoma. Computer tomography additionally found a focal mass in the right parotid gland. Additional examination revealed no contraindications to surgical treatment, after which the patient underwent wide excision of the skin tumor with a reconstructive plastic component, extended cervical lymph node dissection with resection of the parotid salivary gland on the right. Histological examination of postoperative material confirmed the diagnosis. Subsequently, the patient underwent a postoperative course of radiation therapy. No information on recurrence of the disease was received at the time of submission of data for publication. Treatment of Merkel cell carcinoma in elderly patients requires a multidisciplinary approach and can significantly improve the quality of life.

1 January 2023 in Cardiology: News, Opinions, Training
Verified
Journal Article
Open access
VMV.A. Minenok
V.A. Minenok
KUKursk State Medical University
Kursk State Medical University
MSM.A. Stepchenko
M.A. Stepchenko
NMN.S. Mescherina
N.S. Mescherina
AKA.I. Klement’eva
A.I. Klement’eva
VKV.V. Khvostovoy
V.V. Khvostovoy
Кардиотоксические осложнения у больных онкологического профиля: патогенетические механизмы, диагностика, терапия

30 November 2020 in Journal of Modern Oncology
Verified
Journal Article
Open access
PDF file
LSL. V. Silina
L. V. Silina
VKV. V. Khvostovoi
V. V. Khvostovoi
VOV. V. Ovsianikov
V. V. Ovsianikov
MZM. S. Zubtsov
M. S. Zubtsov
Aim.Comparison of the results of the use of dermatoscopic algorithms Chaos and Clues, Triage Amalgamated Dermoscopic Algorithm (TADA) and BLINCK technique in the diagnosis of melanoma and other malignant skin tumors depending on the presence of previous dermatoscopy experience. Materials and methods.Algorithms were tested on 85 patients with 85 skin formations who visited the polyclinic of Kursk Regional Clinical Oncology Clinic in 20172019. The average age of the patients was 54.8 years old. Dermatoscopy was performed by the non-polarized dermatoscope HEINE mini 3000, photo documentation by the Canon PowerShot SX540 HS camera. Immersion medium ethyl alcohol (conc. 70%). Patients were carefully examined physiologically and clinically. A clinical and epiluminescence pattern of all neoplasms was obtained, their morphological examination was performed. For the research 2 groups of 3 participants were formed based on the criterion of previous dermatoscopy experience. Each algorithm was evaluated by objective (sensitivity, specificity) and subjective (speed, convenience) criteria. The dermatoscopic results obtained by the techniques used were compared to the histological findings. Results. Using algorithms by a group having previous dermatoscopy experience, the following results were obtained: in the method Chaos and Clues sensitivity 93.753.3%, specificity 77.44.6%, speed 3 points, convenience 3 points. TADA sensitivity 96.82.2%, specificity 79.24.8%, speed 4 points, convenience 5 points. BLINCK sensitivity 96.82.2% specificity 77.44.6%, speed 4 points, convenience 5 points. In the group with no previous dermatoscopy experience, the results were as follows: in the Chaos and Clues algorithm, sensitivity 93.753.3%, specificity 62.35.7%, speed 3 points, convenience 3 points. TADA sensitivity 84.44.6%, specificity 64.25.8%, speed 4 points, convenience 5 points; BLINCK sensitivity 80.64.4%, specificity 77.44.6%, speed 5 points, convenience 4 points. Thus, these algorithms can be used in the diagnosis of malignant skin neoplasms. At the same time, individuals with no experience of dermatoscopy are encouraged to use the Chaos and Clues algorithm. In a group having experience in dermatoscopy, both the TADA and the BLINCK technique can be used equally.